A PHASE I TRIAL OF LENALIDOMIDE IN COMBINATION WITH INTERMEDIATE DOSE CYTARABINE (IDC) IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) PATIENTS

被引：0
|
作者：
Vigil, E. [1 ]
Griffiths, A. [1 ]
Thompson, E. [1 ]
Brady, E. [1 ]
Dickey, M. [1 ]
Ford, A. [1 ]
Wang, S. [1 ]
Wetzler, M. [1 ]
机构：
[1] Roswell Park Canc Inst, Buffalo, NY 14263 USA
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0082
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [21] Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study
    Norbert Vey
    Hagop Kantarjian
    Miloslav Beran
    Susan O'Brien
    Jorge Cortes
    Charles Koller
    Elihu Estey
    [J]. Investigational New Drugs, 1999, 17 : 89 - 95
  • [22] Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study
    Vey, N
    Kantarjian, H
    Beran, M
    O'Brien, S
    Cortes, J
    Koller, C
    Estey, E
    [J]. INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) : 89 - 95
  • [23] A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Tsimberidou, Apostolia Maria
    Keating, Michael J.
    Jabbour, Elias J.
    Ravandi-Kashani, Farhad
    O'Brien, Susan
    Estey, Elihu
    Bekele, Neby
    Plunkett, William K., Jr.
    Kantarjian, Hagop
    Borthakur, Gautam
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (05): : 395 - 400
  • [24] PHARMACOKINETICS OF SELINEXOR IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: A PHASE I TRIAL.
    Badawi, M.
    Walker, A.
    Mims, A.
    Vasu, S.
    Blum, W.
    Klisovic, R.
    Bhatnagar, B.
    Phelps, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S51 - S51
  • [25] Limited phase I trial of sequential high dose cytarabine and clofarabine (HiDAC→CLOF) in relapsed or refractory acute myeloid leukemia.
    Powell, Bayard L.
    Lovato, James
    Kimbrough, Claire
    Lyerly, Susan
    Galloway-Daniels, Sonya
    Motley, Cathy
    Harrelson, Robin
    Keung, Yi Kong
    Thakuri, Mohan C.
    Molnar, Istvan
    Levitan, Denise
    Hurd, David Duane
    [J]. BLOOD, 2006, 108 (11) : 221B - 221B
  • [26] IDARUBICIN IN COMBINATION WITH INTERMEDIATE-DOSE CYTARABINE AND VP-16 IN THE TREATMENT OF REFRACTORY OR RAPIDLY RELAPSED PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    CARELLA, AM
    CARLIER, P
    PUNGOLINO, E
    RESEGOTTI, L
    LISO, V
    STASI, R
    MONTILLO, M
    IACOPINO, P
    MIRTO, S
    PAGANO, L
    LEONI, F
    MARTELLI, FM
    DIRAIMONDO, F
    PORCELLINI, A
    DERIU, L
    NOSARI, AM
    CIMINO, R
    DAMASIO, E
    MIRAGLIA, E
    FIORITONI, G
    RICCIUTI, F
    CAROTENUTO, M
    LONGINOTTI, M
    DEFAZIO, D
    FAZI, P
    MANDELLI, F
    [J]. LEUKEMIA, 1993, 7 (02) : 196 - 199
  • [27] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Attar, Eyal C.
    Amrein, Philip C.
    Fraser, James W.
    Fathi, Amir T.
    McAfee, Steven
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Stone, Richard M.
    Foster, Julia
    Neuberg, Donna
    Ballen, Karen K.
    [J]. LEUKEMIA RESEARCH, 2013, 37 (09) : 1016 - 1020
  • [28] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Amrein, Philip C.
    Attar, Eyal C.
    Fathi, Amir Tahmasb
    McAfee, Steven L.
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Foster, Julia
    Stone, Richard M.
    Neuberg, Donna S.
    Ballen, Karen K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] APhase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia
    Advani, Anjali S.
    Cooper, Brenda
    Visconte, Valeria
    Elson, Paul
    Chan, Ricky
    Carew, Jennifer
    Wei, Wei
    Mukherjee, Sudipto
    Gerds, Aaron
    Carraway, Hetty
    Nazha, Aziz
    Hamilton, Betty
    Sobecks, Ronald
    Caimi, Paolo
    Tomlinson, Benjamin
    Malek, Ehsan
    Little, Jane
    Miron, Alexander
    Pink, John
    Maciejewski, Jaroslaw
    Unger, Allison
    Kalaycio, Matt
    de Lima, Marcos
    Sekeres, Mikkael A.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4231 - 4237
  • [30] A Phase I Trial of Escalating Dose of the Rapamycin Analog Everolimus in Combination with the Kinase Inhibitor Midostaurin in Patients (pts) with Relapsed, Refractory or Poor Prognosis Acute Myeloid Leukemia (AML)
    Stone, Richard M.
    Driscoll, Caitlin
    Galinsky, Ilene
    Wadleigh, Martha
    Steensma, David P.
    Avigan, David
    Amrein, Philip C.
    Liu, Suiyang
    Griffin, James D.
    McAfee, Steven L.
    Attar, Eyal C.
    Ballen, Karen K.
    Fox, Edward
    DeAngelo, Daniel J.
    [J]. BLOOD, 2012, 120 (21)
12345